Injection Site Reaction to Extended-Release Buprenorphine (Sublocade<sup>®</sup>) for Opioid Use Disorder Fourteen Days after Administration.

Injection Site Reaction to Extended-Release Buprenorphine (Sublocade^®) for Opioid Use Disorder Fourteen Days after Administration.

Weesner, Elizabeth; Ghassemi, Hosain; Salapenka, Iryna; Konakanchi, Jaya Sri; Maggio, Gregory; Sethi, Roopa.

Afiliação

Weesner E; University of Kansas School of Medicine, Kansas City, KS.
Ghassemi H; University of Kansas School of Medicine, Kansas City, KS.
Salapenka I; Department of Psychiatry and Behavioral Sciences, University of Kansas Health System, Kansas City, KS.
Konakanchi JS; University of Kansas School of Medicine, Kansas City, KS.
Maggio G; Department of Psychiatry and Behavioral Sciences, University of Kansas Health System, Kansas City, KS.
Sethi R; Department of Psychiatry and Behavioral Sciences, University of Kansas Health System, Kansas City, KS.

Kans J Med ; 15: 302-304, 2022.

Article em En | MEDLINE | ID: mdl-36042837